Page 49 - Glass Machinery Plants & Accessories no. 6-2019
P. 49
packaging market was dominated tial drug/container interaction. By harnessing big data, we have
by the glass packaging, which It is because of its specifications moved from a statistical sample-
has also witnessed considerable that borosilicate glass is used based quality-control process to
competition from plastic man- to package a number of drugs 100 per cent inspection of each
ufacturers over the years. So, including highly sensitive drug FIOLAX tube.”
how has SCHOTT ensured that formulations.” Thus, its existing SCHOTT’s pharma packaging
its clientele continues to prefer products and their quality have experts also see a few trends in
their glass solutions? Why should continued to keep their clientele the primary packaging industry
they choose glass packaging over happy and content. itself. For example, an increase
plastic solutions? Moreover, it has adopted newer in formulations with sensitive
Markschlaeger answers technologies from Germany to and complex molecule structures,
these questions and says, “An meet the growing demands of the e.g. biotech drugs, which require
unmatched combination of our Indian market. Markschlaeger innovative packaging solutions
high-quality production stand- points out, “India serves as an to ensure drug stability. Another
ards, truly global footprint and ideal example for Industry 4.0 – trend shaping the industry is the
technological expertise has the current trend of automation move from hospital to home care
established SCHOTT as a mar- and data exchange in manufac- to enable patients to self-admin-
ket leader, globally as well as in turing technologies. The Indian ister the drugs in an environ-
India.” plant showcases main elements ment they feel most comfort-
He further elaborates on of a ‘smart factory’ through able in. Such patterns require the
a few of their renowned and path-breaking technologies such containers and subsequently the
widely-used products, “When as perfeXion. For example, last tubing to have highly accurate
it comes to choosing a suitable year, SCHOTT implemented dimensions, especially regarding
primary packaging for drugs, perfeXion in Jambusar - the the inside diameter. We achieve
pharma companies have relied new era of quality processing to this through perfeXion, which
on FIOLAX pharma containers achieve exceptional quality con- allowed us to step into a new era
for over 100 years. This type I trol standards for its FIOLAX of quality processing.”
borosilicate glass features high pharma glass tubing. perfeXion
hydrolytic resistance, hence pre- uses state-of-the-art cameras GROWTH STRATEGIES FOR
serving the efficacy of medicine and lasers to pinpoint potential INDIA
and reducing the risk of a poten- defects along the production line. With these products, the
company has captured signifi-
cant market presence in India,
and with its recent INR 180
crore investment at Jambusar,
it intends to increase it produc-
tion capacity by 50 per cent. The
increased capacity will not only
cater to the increasing domestic
demands but also to the need for
high-quality pharma glass tubing
in other Asian markets.
Markschlaeger explains about
the features of the new facil-
ity and its advantages, “With an
additional tank facility, SCHOTT
will also build new construction
for energy supply, workshops
and warehouse. Additionally,
there will be an expansion of
storage for energy, engineer-
ing and logistics infrastructure
within the plant. With our pro-
duction capacity set to increase
by another 50 per cent through
the new plant, we look forward
glass machinery plants & accessories 6/2019 47
